de Haan L - Search Results

1

Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications.

de Haan L, Lavalaye J, van Bruggen M, van Nimwegen L, Booij J, van Amelsvoort T, Linszen D. de Haan L, et al. Can J Psychiatry. 2004 May;49(5):290-6. doi: 10.1177/070674370404900503. Can J Psychiatry. 2004. PMID: 15198464 Review.

2

Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders.

de Haan L, Beuk N, Hoogenboom B, Dingemans P, Linszen D. de Haan L, et al. J Clin Psychiatry. 2002 Feb;63(2):104-7. doi: 10.4088/jcp.v63n0203. J Clin Psychiatry. 2002. PMID: 11874209 Clinical Trial.

3

Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study.

de Haan L, van Bruggen M, Lavalaye J, Booij J, Dingemans PM, Linszen D. de Haan L, et al. Am J Psychiatry. 2003 Feb;160(2):303-9. doi: 10.1176/appi.ajp.160.2.303. Am J Psychiatry. 2003. PMID: 12562577 Clinical Trial.

4

Attitudes of patients toward the first psychotic episode and the start of treatment.

de Haan L, Peters B, Dingemans P, Wouters L, Linszen D. de Haan L, et al. Schizophr Bull. 2002;28(3):431-42. doi: 10.1093/oxfordjournals.schbul.a006951. Schizophr Bull. 2002. PMID: 12645675

5

Duration of untreated psychosis and outcome of schizophrenia: delay in intensive psychosocial treatment versus delay in treatment with antipsychotic medication.

de Haan L, Linszen DH, Lenior ME, de Win ED, Gorsira R. de Haan L, et al. Among authors: de win ed. Schizophr Bull. 2003;29(2):341-8. doi: 10.1093/oxfordjournals.schbul.a007009. Schizophr Bull. 2003. PMID: 14552508

6

Elevated homocysteine levels in schizophrenia.

de Haan L, van Amelsvoort T, Linszen DH. de Haan L, et al. Am J Psychiatry. 2004 Jun;161(6):1131-2; author reply 1132. doi: 10.1176/appi.ajp.161.6.1131-a. Am J Psychiatry. 2004. PMID: 15169714 No abstract available.

7

Weight loss after switching from conventional olanzapine tablets to orally disintegrating olanzapine tablets.

de Haan L, van Amelsvoort T, Rosien K, Linszen D. de Haan L, et al. Psychopharmacology (Berl). 2004 Sep;175(3):389-90. doi: 10.1007/s00213-004-1951-2. Psychopharmacology (Berl). 2004. PMID: 15322727 Clinical Trial. No abstract available.

8

Obsessive-compulsive disorder and treatment with clozapine in 200 patients with recent-onset schizophrenia or related disorders.

De Haan L, Oekeneva A, Van Amelsvoort T, Linszen D. De Haan L, et al. Eur Psychiatry. 2004 Dec;19(8):524. doi: 10.1016/j.eurpsy.2004.09.022. Eur Psychiatry. 2004. PMID: 15589719 No abstract available.

9

Comfort, self-confidence, safety, and dopamine D2 receptor occupancy by antipsychotics.

de Haan L, Lavalaye J, Booij J, Linszen D. de Haan L, et al. Am J Psychiatry. 2005 Aug;162(8):1544-5. doi: 10.1176/appi.ajp.162.8.1544. Am J Psychiatry. 2005. PMID: 16055785 No abstract available.

10

Subjective experiences during dopamine depletion.

de Haan L, Booij J, Lavalye J, van Amelsvoort T, Linszen D. de Haan L, et al. Am J Psychiatry. 2005 Sep;162(9):1755. doi: 10.1176/appi.ajp.162.9.1755. Am J Psychiatry. 2005. PMID: 16135643 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

922 results

Search Page

Filters